Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery - PubMed (original) (raw)
Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery
Gary M Jacobson et al. Circ Res. 2003.
Abstract
Neointimal proliferation occurring after vascular or endovascular procedures is a major complication leading to end-organ or limb ischemia. In experimental models, balloon injury has been shown to induce NAD(P)H oxidase to produce vascular superoxide anion (O2*-) production, which has been implicated in cell proliferation, but a direct link is still unclear. We postulated that inhibition of arterial NAD(P)H oxidase, resulting in decreased O2*-, would lessen the neointimal hyperplasia caused by balloon injury to the common carotid artery (CCA). Sprague-Dawley rats were implanted with osmotic minipumps containing either vehicle, a cell-permeant peptide that inhibits NAD(P)H oxidase (gp91ds-tat, 10 mg/kg per day), or a scrambled peptide control (scrmb-tat). Two days after pump implantation, the left CCA was injured using an intravascular balloon embolectomy catheter (2F Fogarty). Systolic blood pressure was monitored by tail cuff. Fourteen days after injury, CCAs were harvested and analyzed by digital morphometry. Rats in both groups remained normotensive, with no significant differences in systolic blood pressure. Reactive oxygen species measurements after injury indicated a significant reduction in vascular O2*- in rats infused with gp91ds-tat, and the neointima/media area and thickness ratios were significantly lower in their arteries compared with control. On the contrary, no significant change in overall CCA diameter was observed in any group. Our data indicate that in response to balloon injury of the rat carotid artery, NAD(P)H oxidase activity contributes to neointimal hyperplasia and is involved in vascular cell proliferation and migration during restenosis.
Comment in
- A radical adventure: the quest for specific functions and inhibitors of vascular NAPDH oxidases.
Brandes RP. Brandes RP. Circ Res. 2003 Apr 4;92(6):583-5. doi: 10.1161/01.RES.0000066880.62205.B0. Circ Res. 2003. PMID: 12676809 No abstract available.
Similar articles
- Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
Park SJ, Kim HS, Yang HM, Park KW, Youn SW, Jeon SI, Kim DH, Koo BK, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB. Park SJ, et al. Arterioscler Thromb Vasc Biol. 2004 May;24(5):885-91. doi: 10.1161/01.ATV.0000124924.21961.c3. Epub 2004 Feb 26. Arterioscler Thromb Vasc Biol. 2004. PMID: 14988093 - Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K, Yui N, Matsumoto C, Mori T, Ohkita M, Matsumura Y. Kitada K, et al. J Pharmacol Exp Ther. 2009 Dec;331(3):998-1004. doi: 10.1124/jpet.109.157065. Epub 2009 Sep 8. J Pharmacol Exp Ther. 2009. PMID: 19737855 - Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery.
Dourron HM, Jacobson GM, Park JL, Liu J, Reddy DJ, Scheel ML, Pagano PJ. Dourron HM, et al. Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H946-53. doi: 10.1152/ajpheart.00413.2004. Epub 2004 Sep 23. Am J Physiol Heart Circ Physiol. 2005. PMID: 15388496 - In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Gene Ther. 2001 Apr;8(7):534-41. doi: 10.1038/sj.gt.3301437. Gene Ther. 2001. PMID: 11319620 - Total Ginsenosides suppress the neointimal hyperplasia of rat carotid artery induced by balloon injury.
Yu XF, Deng J, Yang DL, Gao Y, Gong QH, Huang XN. Yu XF, et al. Vascul Pharmacol. 2011 Jan-Feb;54(1-2):52-7. doi: 10.1016/j.vph.2010.12.003. Epub 2010 Dec 25. Vascul Pharmacol. 2011. PMID: 21187161
Cited by
- Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.
Armitage ME, Wingler K, Schmidt HH, La M. Armitage ME, et al. J Mol Med (Berl). 2009 Nov;87(11):1071-6. doi: 10.1007/s00109-009-0544-2. Epub 2009 Oct 16. J Mol Med (Berl). 2009. PMID: 19834654 Free PMC article. Review. - Redox control of vascular smooth muscle migration.
San Martín A, Griendling KK. San Martín A, et al. Antioxid Redox Signal. 2010 Mar 1;12(5):625-40. doi: 10.1089/ars.2009.2852. Antioxid Redox Signal. 2010. PMID: 19737088 Free PMC article. Review. - Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration.
Ranayhossaini DJ, Rodriguez AI, Sahoo S, Chen BB, Mallampalli RK, Kelley EE, Csanyi G, Gladwin MT, Romero G, Pagano PJ. Ranayhossaini DJ, et al. J Biol Chem. 2013 Dec 20;288(51):36437-50. doi: 10.1074/jbc.M113.521344. Epub 2013 Nov 1. J Biol Chem. 2013. PMID: 24187133 Free PMC article. - Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".
Dahan I, Pick E. Dahan I, et al. Cell Mol Life Sci. 2012 Jul;69(14):2283-305. doi: 10.1007/s00018-012-1007-4. Epub 2012 May 6. Cell Mol Life Sci. 2012. PMID: 22562603 Free PMC article. Review. - Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model.
Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey SC. Zhu Y, et al. J Neurosci. 2007 Sep 12;27(37):10060-71. doi: 10.1523/JNEUROSCI.0857-07.2007. J Neurosci. 2007. PMID: 17855620 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical